Drug Profile
Research programme: macrolide antibacterials - Zikani Therapeutics
Alternative Names: Antibacterials - Zikani Therapeutics; Antibiotics - Zikani Therapeutics; Macrolide antibiotics - Zikani TherapeuticsLatest Information Update: 24 Aug 2022
Price :
$50
*
At a glance
- Originator Macrolide Pharmaceuticals
- Developer Zikani Therapeutics
- Class Antibacterials; Macrolides; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections